4
Changes in Ownership
PMV Pharmaceuticals, Inc. Filed Acc 0001415889-24-024624
Options or other derivatives
- Chief Financial Officer acquired 115,805 shares (grant or award)
- Chief Financial Officer returned 115,805 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Carulli Michael Chief Financial Officer | 2024-08-13 | Returned to the company · Employee Stock Option (right to buy) | −13,605 | 0 | D | ||
| Carulli Michael Chief Financial Officer | 2024-08-13 | Returned to the company · Employee Stock Option (right to buy) | −27,200 | 0 | D | ||
| Carulli Michael Chief Financial Officer | 2024-08-13 | Grant or award · Employee Stock Option (right to buy) | +40,805 | 40,805 | D | ||
| Carulli Michael Chief Financial Officer | 2024-08-13 | Returned to the company · Employee Stock Option (right to buy) | −75,000 | 75,000 | D | ||
| Carulli Michael Chief Financial Officer | 2024-08-13 | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | D | ||
Loading xslF345X05/form4-10032024_081040.xml…